Selected research
Industry Growth & Trends
Global Tissue Sealants Industry Growth and Trends Forecast to 2032
Market perspective
The global Tissue Sealants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tissue Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tissue Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tissue Sealants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tissue Sealants include Advanced Medical Solutions Group, C. R. Bard, Cardinal Health, Cohera Medical, Cryolife, CSL Behring, Haemacure, HyperBranch Medical Technology and Integra LifeSciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tissue Sealants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tissue Sealants market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tissue Sealants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tissue Sealants.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Tissue Sealants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tissue Sealants Market by Company
Advanced Medical Solutions Group
C. R. Bard
Cardinal Health
Cohera Medical
Cryolife
CSL Behring
Haemacure
HyperBranch Medical Technology
Integra LifeSciences
NeoMend
Smith & Nephew
Teijin Pharma
Tissuemed
Vascular Solutions
Vivostat
Z-Medica
Baxter International
B. Braun
Johnson & Johnson
Tissue Sealants Segment by Type
Fibrin
Synthetic Sealant
Tissue Sealants Segment by Application
Hospitals
Research Institutions
Tissue Sealants Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Sealants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue Sealants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Sealants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Sealants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Tissue Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fibrin
- Synthetic Sealant
Applications
- Hospitals
- Research Institutions
Companies covered
- Advanced Medical Solutions Group
- C. R. Bard
- Cardinal Health
- Cohera Medical
- Cryolife
- CSL Behring
- Haemacure
- HyperBranch Medical Technology
- Integra LifeSciences
- NeoMend
- Smith & Nephew
- Teijin Pharma
- Tissuemed
- Vascular Solutions
- Vivostat
- Z-Medica
- Baxter International
- B. Braun
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tissue Sealants Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Tissue Sealants Sales Estimates and Forecasts (2021-2032)
- 1.3 Tissue Sealants Market by Type
- 1.3.1 Fibrin
- 1.3.2 Synthetic Sealant
- 1.4 Global Tissue Sealants Market Size by Type
- 1.4.1 Global Tissue Sealants Market Size Overview by Type (2021-2032)
- 1.4.2 Global Tissue Sealants Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Tissue Sealants Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Tissue Sealants Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Tissue Sealants Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Tissue Sealants Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Tissue Sealants Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Tissue Sealants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Tissue Sealants Industry Trends
- 2.2 Tissue Sealants Industry Drivers
- 2.3 Tissue Sealants Industry Opportunities and Challenges
- 2.4 Tissue Sealants Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Tissue Sealants Revenue (2021-2026)
- 3.2 Global Top Players by Tissue Sealants Sales (2021-2026)
- 3.3 Global Top Players by Tissue Sealants Price (2021-2026)
- 3.4 Global Tissue Sealants Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tissue Sealants Major Company Production Sites & Headquarters
- 3.6 Global Tissue Sealants Company, Product Type & Application
- 3.7 Global Tissue Sealants Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tissue Sealants Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tissue Sealants Players Market Share by Revenue in 2025
- 3.8.3 2025 Tissue Sealants Tier 1, Tier 2, and Tier 3
4 Tissue Sealants Regional Status and Outlook
- 4.1 Global Tissue Sealants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Tissue Sealants Historic Market Size by Region
- 4.2.1 Global Tissue Sealants Sales in Volume by Region (2021-2026)
- 4.2.2 Global Tissue Sealants Sales in Value by Region (2021-2026)
- 4.2.3 Global Tissue Sealants Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Tissue Sealants Forecasted Market Size by Region
- 4.3.1 Global Tissue Sealants Sales in Volume by Region (2027-2032)
- 4.3.2 Global Tissue Sealants Sales in Value by Region (2027-2032)
- 4.3.3 Global Tissue Sealants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tissue Sealants by Application
- 5.1 Tissue Sealants Market by Application
- 5.1.1 Hospitals
- 5.1.2 Research Institutions
- 5.2 Global Tissue Sealants Market Size by Application
- 5.2.1 Global Tissue Sealants Market Size Overview by Application (2021-2032)
- 5.2.2 Global Tissue Sealants Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Tissue Sealants Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Tissue Sealants Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Tissue Sealants Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Tissue Sealants Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Tissue Sealants Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Tissue Sealants Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Advanced Medical Solutions Group
- 6.1.1 Advanced Medical Solutions Group Company Information
- 6.1.2 Advanced Medical Solutions Group Business Overview
- 6.1.3 Advanced Medical Solutions Group Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Advanced Medical Solutions Group Tissue Sealants Product Portfolio
- 6.1.5 Advanced Medical Solutions Group Recent Developments
- 6.2 C. R. Bard
- 6.2.1 C. R. Bard Company Information
- 6.2.2 C. R. Bard Business Overview
- 6.2.3 C. R. Bard Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 C. R. Bard Tissue Sealants Product Portfolio
- 6.2.5 C. R. Bard Recent Developments
- 6.3 Cardinal Health
- 6.3.1 Cardinal Health Company Information
- 6.3.2 Cardinal Health Business Overview
- 6.3.3 Cardinal Health Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cardinal Health Tissue Sealants Product Portfolio
- 6.3.5 Cardinal Health Recent Developments
- 6.4 Cohera Medical
- 6.4.1 Cohera Medical Company Information
- 6.4.2 Cohera Medical Business Overview
- 6.4.3 Cohera Medical Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Cohera Medical Tissue Sealants Product Portfolio
- 6.4.5 Cohera Medical Recent Developments
- 6.5 Cryolife
- 6.5.1 Cryolife Company Information
- 6.5.2 Cryolife Business Overview
- 6.5.3 Cryolife Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Cryolife Tissue Sealants Product Portfolio
- 6.5.5 Cryolife Recent Developments
- 6.6 CSL Behring
- 6.6.1 CSL Behring Company Information
- 6.6.2 CSL Behring Business Overview
- 6.6.3 CSL Behring Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CSL Behring Tissue Sealants Product Portfolio
- 6.6.5 CSL Behring Recent Developments
- 6.7 Haemacure
- 6.7.1 Haemacure Company Information
- 6.7.2 Haemacure Business Overview
- 6.7.3 Haemacure Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Haemacure Tissue Sealants Product Portfolio
- 6.7.5 Haemacure Recent Developments
- 6.8 HyperBranch Medical Technology
- 6.8.1 HyperBranch Medical Technology Company Information
- 6.8.2 HyperBranch Medical Technology Business Overview
- 6.8.3 HyperBranch Medical Technology Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 HyperBranch Medical Technology Tissue Sealants Product Portfolio
- 6.8.5 HyperBranch Medical Technology Recent Developments
- 6.9 Integra LifeSciences
- 6.9.1 Integra LifeSciences Company Information
- 6.9.2 Integra LifeSciences Business Overview
- 6.9.3 Integra LifeSciences Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Integra LifeSciences Tissue Sealants Product Portfolio
- 6.9.5 Integra LifeSciences Recent Developments
- 6.10 NeoMend
- 6.10.1 NeoMend Company Information
- 6.10.2 NeoMend Business Overview
- 6.10.3 NeoMend Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 NeoMend Tissue Sealants Product Portfolio
- 6.10.5 NeoMend Recent Developments
- 6.11 Smith & Nephew
- 6.11.1 Smith & Nephew Company Information
- 6.11.2 Smith & Nephew Business Overview
- 6.11.3 Smith & Nephew Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Smith & Nephew Tissue Sealants Product Portfolio
- 6.11.5 Smith & Nephew Recent Developments
- 6.12 Teijin Pharma
- 6.12.1 Teijin Pharma Company Information
- 6.12.2 Teijin Pharma Business Overview
- 6.12.3 Teijin Pharma Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Teijin Pharma Tissue Sealants Product Portfolio
- 6.12.5 Teijin Pharma Recent Developments
- 6.13 Tissuemed
- 6.13.1 Tissuemed Company Information
- 6.13.2 Tissuemed Business Overview
- 6.13.3 Tissuemed Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Tissuemed Tissue Sealants Product Portfolio
- 6.13.5 Tissuemed Recent Developments
- 6.14 Vascular Solutions
- 6.14.1 Vascular Solutions Company Information
- 6.14.2 Vascular Solutions Business Overview
- 6.14.3 Vascular Solutions Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Vascular Solutions Tissue Sealants Product Portfolio
- 6.14.5 Vascular Solutions Recent Developments
- 6.15 Vivostat
- 6.15.1 Vivostat Company Information
- 6.15.2 Vivostat Business Overview
- 6.15.3 Vivostat Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Vivostat Tissue Sealants Product Portfolio
- 6.15.5 Vivostat Recent Developments
- 6.16 Z-Medica
- 6.16.1 Z-Medica Company Information
- 6.16.2 Z-Medica Business Overview
- 6.16.3 Z-Medica Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Z-Medica Tissue Sealants Product Portfolio
- 6.16.5 Z-Medica Recent Developments
- 6.17 Baxter International
- 6.17.1 Baxter International Company Information
- 6.17.2 Baxter International Business Overview
- 6.17.3 Baxter International Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Baxter International Tissue Sealants Product Portfolio
- 6.17.5 Baxter International Recent Developments
- 6.18 B. Braun
- 6.18.1 B. Braun Company Information
- 6.18.2 B. Braun Business Overview
- 6.18.3 B. Braun Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 B. Braun Tissue Sealants Product Portfolio
- 6.18.5 B. Braun Recent Developments
- 6.19 Johnson & Johnson
- 6.19.1 Johnson & Johnson Company Information
- 6.19.2 Johnson & Johnson Business Overview
- 6.19.3 Johnson & Johnson Tissue Sealants Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Johnson & Johnson Tissue Sealants Product Portfolio
- 6.19.5 Johnson & Johnson Recent Developments
7 North America by Country
- 7.1 North America Tissue Sealants Sales by Country
- 7.1.1 North America Tissue Sealants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Tissue Sealants Sales by Country (2021-2026)
- 7.1.3 North America Tissue Sealants Sales Forecast by Country (2027-2032)
- 7.2 North America Tissue Sealants Market Size by Country
- 7.2.1 North America Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Tissue Sealants Market Size by Country (2021-2026)
- 7.2.3 North America Tissue Sealants Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Tissue Sealants Sales by Country
- 8.1.1 Europe Tissue Sealants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Tissue Sealants Sales by Country (2021-2026)
- 8.1.3 Europe Tissue Sealants Sales Forecast by Country (2027-2032)
- 8.2 Europe Tissue Sealants Market Size by Country
- 8.2.1 Europe Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Tissue Sealants Market Size by Country (2021-2026)
- 8.2.3 Europe Tissue Sealants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Tissue Sealants Sales by Country
- 9.1.1 Asia-Pacific Tissue Sealants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Tissue Sealants Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Tissue Sealants Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Tissue Sealants Market Size by Country
- 9.2.1 Asia-Pacific Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Tissue Sealants Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Tissue Sealants Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Tissue Sealants Sales by Country
- 10.1.1 South America Tissue Sealants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Tissue Sealants Sales by Country (2021-2026)
- 10.1.3 South America Tissue Sealants Sales Forecast by Country (2027-2032)
- 10.2 South America Tissue Sealants Market Size by Country
- 10.2.1 South America Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Tissue Sealants Market Size by Country (2021-2026)
- 10.2.3 South America Tissue Sealants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Tissue Sealants Sales by Country
- 11.1.1 Middle East and Africa Tissue Sealants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Tissue Sealants Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Tissue Sealants Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Tissue Sealants Market Size by Country
- 11.2.1 Middle East and Africa Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Tissue Sealants Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Tissue Sealants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Tissue Sealants Value Chain Analysis
- 12.1.1 Tissue Sealants Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Tissue Sealants Production Mode & Process
- 12.2 Tissue Sealants Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Tissue Sealants Distributors
- 12.2.3 Tissue Sealants Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst